Phellamurin



Compound IDCDAMM00207
Common namePhellamurin
IUPAC name(2R,3R)-3,5-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one
Molecular formulaC26H30O11

Experimental data

Retention time49.34
Adduct[M+H]+
Actual mz519.185
Theoretical mz519.186
Error1.15
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.2809

Identifiers and class information

Inchi keyGRDZTDZJQRPNCN-YIPRNBEHNA-N
SmilesCC(=CCC1=C(C=C(C2=C1OC(C(C2=O)O)C3=CC=C(C=C3)O)O)OC4C(C(C(C(O4)CO)O)O)O)C
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)12
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)518.516
Computed dipole moment(dipole)7.569
Total solvent accessible surface area (SASA)765.907
Hydrophobic component of SASA (FOSA)278.199
Hydrophilic component of SASA (FISA)335.682
Pie component of the SASA (PISA)152.026
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1469.44
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)14.2
Free energy of solvation of dipole (dip^2/V)0.0389844
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0454138
Globularity descriptor (glob)0.816127
Predicted polarizability in cubic angstroms (QPpolrz)46.4
Predicted hexadecane/gas partition coefficient (QPlogPC16)16.629
Predicted octanol/gas partition coefficient (QPlogPoct)33.037
Predicted water/gas partition coefficient (QPlogPw)25.007
Predicted octanol/water partition coefficient (QPlogPo/w)0.036
Predicted aqueous solubility (QPlogS)-3.472
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.773
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.232
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)6.496
Predicted brain/blood partition coefficient (QPlogBB)-3.52
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2.138
Predicted skin permeability, log Kp (QPlogKp)-6.018
PM3 calculated ionization potential (IP(ev))9.024
PM3 calculated electron affinity (EA(eV))0.347
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)-0.563
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)2.827
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)198.269
Number of nitrogen and oxygen atoms (#NandO)11
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P11387TOP1DNA topoisomerase IT09826SEA
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P01112HRASTransforming protein p21/H-Ras-1T71081SEA
P60568IL2Interleukin-2T61698SEA
P14679TYRTyrosinaseT97035SEA
P63316TNNC1Troponin, cardiac muscleT12966SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P05231IL6Interleukin-6T32578SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA
P19429TNNI3Cardiac troponin IT20186SEA
P45379TNNT2Cardiac muscle troponin TT05887SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T09826DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P11387TOP1
T09826DI0095Colorectal cancer[ICD-11: 2B91]P11387TOP1
T09826DI0238Lung cancer[ICD-11: 2C25]P11387TOP1
T09826DI0321Ovarian cancer[ICD-11: 2C73]P11387TOP1
T09826DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P11387TOP1
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T12966DI0006Acquired cutaneous blood vessel malformation[ICD-11: EF20]P63316TNNC1
T12966DI0175Heart failure[ICD-11: BD10-BD1Z]P63316TNNC1
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025